References
- Agner AR, Maciel MAM, Pinto AC, Cólus IMS. Antigenotoxicity of trans-dehydrocrotonin, a clerodane diterpene from Croton cajucara. Planta Med 2001; 67: 815–819
- Agner AR, Maciel MAM, Pinto AC, Pamplona SGS, Cólus IMS. Investigation of genotoxic activity of trans-dehydrocrotonin, a clerodane diterpene from Croton cajucara. Teratogen Carcinogen Mutagen 1999; 19: 377–384
- Ain Q, Sharma S, Garg SK, Khuller GK. Role of poly[Dl-lactide-co-glycolide] in development of a sustained oral delivery system for antitubercular drug(s). Int J Pharm 2002; 239: 37–46
- Berkland C, King M, Cox A, Kim K, Pack DW. Precise control of PLG microspheres size provides enhanced control of drug release rate. J Contr Rel 2002; 82: 137–147
- Bnouham M, Ziyyat A, Mekhfi H, Tahri A, Legssyer A. Medicinal plants with potential antidiabetic activity—a review of ten years of herbal medicine research (1990–2000). Int J Diabetes Metab 2006; 14: 1–25
- Farias RAF, Rao VSN, Viana GSB, Silveira ER, Maciel MAM, Pinto AC. Hypoglycemic effect of trans-dehydrocrotonin, a nor-clerodane diterpene from Croton cajucara. Planta Med 1997; 63: 558–560
- Feng SS, Ruan G, Li QT. Fabrication and characterizations of a novel drug delivery device liposomes-in-microspheres (LIM). Biomaterials 2004; 25: 5181–5189
- Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm 2004; 282: 1–18
- Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: Reviewing the state of the art of microsphere preparation process technology. J Contr Rel 2005; 102: 313–332
- Fu X, Ping Q, Gao Y. Effects of formulation factors on encapsulation efficiency and release behavior in vitro of huperzine A-PLGA microspheres. J Microencapsulation 2005; 22: 705–714
- Gabor F, Ertl B, Wirth M, Mallinger R. Ketoprofen-poly(D,L-lacticco-glycolic acid) microspheres: Influence of manufacturing parameters and type of polymer on the release characteristics. J Microencapsulation 1999; 16: 1–12
- Gupta A, Ciftci K. Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel + 5-FU microspheres. Int J Pharm 2004; 276: 93–106
- Klose D, Siepmann F, Elkharraz K, Krenzlin S, Siepmann J. How porosity and size affect the drug release mechanisms from PLGA-based microparticles. Int J Pharm 2006; 314: 198–206
- Krishnamachari Y, Madan P, Senshang Lin S. Development of pH- and time-dependent oral microparticles to optimise budesonide delivery to ileum and colon. Int J Pharm 2007; 338: 238–247
- Maciel MAM, Pinto AC, Arruda AC, Pamplona SGSR, Vanderlinde FA, Lapa AJ, et al. Ethnopharmacology, phytochemistry and pharmacology: A successful combination in the study of Croton cajucara. J Ethnopharmacol 2000; 70: 41–55
- Maciel MAM, Pinto AC, Veiga Jr VF, Martins JR, Grynberg NF, Achevarria A, et al. Croton cajucara as an alternative to traditional medicine in a modern health system. Rec Prog Med Plants 2002; 8: 502–517
- Mao Z, Ma L, Gao C, Shen J. Preformed microcapsules for loading and sustained release of ciprofloxacin hydrochloride. J Contr Rel 2005; 104: 193–202
- Ribeiro-Costa RM, Alves AJ, Santos NP, Nascimento SC, Gonçalves ECP, Silva NH, et al. In vitro and in vivo properties of usnic acid encapsulated into PLGA-microspheres. J Microencapsulation 2004; 21: 371–384
- Siepmann J, Elkharraz K, Siepmann F, Klose D. How autocatalysis accelerates drug release from PLGA-based microparticles: A quantitative treatment. Biomacromolecules 2005; 6: 2312–2319
- Silva RM, Santos FA, Rao VSN, Maciel MAM, Pinto AC. Blood glucose-and triglyceride-lowering effect of trans-dehydrocrotonin, a diterpene from Croton cajucara Beth., in rats. Diabetes Obesity Metab 2001; 3: 452–456
- Veiga Jr VF, Pinto AC, Maciel MAM. Medicinal plants: Safe cure?. Quim Nova 2005; 28: 519–528
- Zhang H, Gao S. Temozolomide/PLGA microparticles and antitumor activity against Glioma C6 cancer cells in vitro. Int J Pharm 2007; 329: 122–128